Sarah-Jane Larkin has been appointed director general of the Irish Venture Capital Association (IVCA). Ms Larkin was formerly commercial director of MSD (Merck – NYSE: MRK). She has worked at director level in the healthcare and medical device sectors for over a decade for organisations including J&J, Sisk Healthcare and the Irish Medical & Surgical Trade Association.
A graduate of UCD, she holds an MBA from the Smurfit Business School.
Commenting on her appointment Ms Larkin said, “At a time of huge global change it is more important than ever for Ireland to accelerate the development of indigenous high potential companies and the IVCA has a critical role to play in this.”
The Irish Venture Capital Association (https://www.ivca.ie) is the representative organisation for venture capital firms in Ireland. Since the onset of the credit crunch in 2008, more than 1,450 Irish SMEs raised venture capital of €3.6bn.
These funds were raised almost exclusively by Irish VC fund managers who during this period supported the creation of up to 20,000 jobs; attracted over €1.6bn of capital into Ireland and geared up the State’s investment through the Seed & Venture Capital Programme by almost 16 times.
Ms Larkin replaces Regina Breheny who has taken up another role in financial services.
Peter Sandys, chairman, IVCA commented, “We are delighted to attract someone of the calibre of Sarah-Jane to replace Regina who, over 14 years, has contributed hugely the growth of the venture capital business in Ireland. The IVCA would like to put on record our thanks and appreciation of Regina’s contribution.”
Ronnie Simpson, Simpson Consulting, Email: email@example.com
Mob: 086 855 9410